InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research. It operates through the InMed Pharma and BayMedica segments. The InMed Pharma segment is organized around the research and development of small molecule pharmaceuticals drug candidates. The BayMedica segment focuses on the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. It is also involved in cannabinoid-based therapies and a biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13
Frequently Asked Questions
What is Market Cap of InMed Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. InMed Pharmaceuticals Inc market cap is $2.58M.
What is the 52-week high for InMed Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. InMed Pharmaceuticals Inc 52 week high is $8.27 as of September 14, 2025.
What is the 52-week low for InMed Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. InMed Pharmaceuticals Inc 52 week low is $1.72 as of September 14, 2025.
What is InMed Pharmaceuticals Inc stock price today?
InMed Pharmaceuticals Inc stock price today is $2.14.
What was InMed Pharmaceuticals Inc stock price yesterday?
InMed Pharmaceuticals Inc stock price yesterday was $2.16.
What is the PE ratio of InMed Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. InMed Pharmaceuticals Inc’s P/E ratio is -0.17.
What is the Price-to-Book ratio of InMed Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. InMed Pharmaceuticals Inc P/B ratio is 0.3679.
What is the 50-day moving average of InMed Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. InMed Pharmaceuticals Inc 50-day moving average is $2.42.
How many employess does InMed Pharmaceuticals Inc has?
